Literature DB >> 29281826

Converging Mechanisms of p53 Activation Drive Motor Neuron Degeneration in Spinal Muscular Atrophy.

Christian M Simon1, Ya Dai1, Meaghan Van Alstyne1, Charalampia Koutsioumpa1, John G Pagiazitis1, Joshua I Chalif1, Xiaojian Wang1, Joseph E Rabinowitz2, Christopher E Henderson3, Livio Pellizzoni4, George Z Mentis5.   

Abstract

The hallmark of spinal muscular atrophy (SMA), an inherited disease caused by ubiquitous deficiency in the SMN protein, is the selective degeneration of subsets of spinal motor neurons. Here, we show that cell-autonomous activation of p53 occurs in vulnerable but not resistant motor neurons of SMA mice at pre-symptomatic stages. Moreover, pharmacological or genetic inhibition of p53 prevents motor neuron death, demonstrating that induction of p53 signaling drives neurodegeneration. At late disease stages, however, nuclear accumulation of p53 extends to resistant motor neurons and spinal interneurons but is not associated with cell death. Importantly, we identify phosphorylation of serine 18 as a specific post-translational modification of p53 that exclusively marks vulnerable SMA motor neurons and provide evidence that amino-terminal phosphorylation of p53 is required for the neurodegenerative process. Our findings indicate that distinct events induced by SMN deficiency converge on p53 to trigger selective death of vulnerable SMA motor neurons.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SMA; SMN; cell death; motor neurons; neurodegenerative disease; p53; phosphorylation; spinal muscular atrophy; survival motor neuron

Mesh:

Substances:

Year:  2017        PMID: 29281826      PMCID: PMC5747328          DOI: 10.1016/j.celrep.2017.12.003

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  69 in total

1.  Abolishing Trp53-dependent apoptosis does not benefit spinal muscular atrophy model mice.

Authors:  Ming Shiun Tsai; Yung Tsung Chiu; Sue Hong Wang; Hsiu Mei Hsieh-Li; Hung Li
Journal:  Eur J Hum Genet       Date:  2006-03       Impact factor: 4.246

2.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

Authors:  P G Komarov; E A Komarova; R V Kondratov; K Christov-Tselkov; J S Coon; M V Chernov; A V Gudkov
Journal:  Science       Date:  1999-09-10       Impact factor: 47.728

3.  SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.

Authors:  Thanh T Le; Lan T Pham; Matthew E R Butchbach; Honglai L Zhang; Umrao R Monani; Daniel D Coovert; Tatiana O Gavrilina; Lei Xing; Gary J Bassell; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2005-02-09       Impact factor: 6.150

Review 4.  Post-translational modification of p53 in tumorigenesis.

Authors:  Ann M Bode; Zigang Dong
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

5.  Sensory-Derived Glutamate Regulates Presynaptic Inhibitory Terminals in Mouse Spinal Cord.

Authors:  Michael Mende; Emily V Fletcher; Josephine L Belluardo; Joseph P Pierce; Praveen K Bommareddy; Jarret A Weinrich; Zeeba D Kabir; Kathryn C Schierberl; John G Pagiazitis; Alana I Mendelsohn; Anna Francesconi; Robert H Edwards; Teresa A Milner; Anjali M Rajadhyaksha; Peter J van Roessel; George Z Mentis; Julia A Kaltschmidt
Journal:  Neuron       Date:  2016-06-02       Impact factor: 17.173

Review 6.  Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases.

Authors:  Fabio Sambataro; Maria Pennuto
Journal:  Prog Neurobiol       Date:  2011-11-02       Impact factor: 11.685

Review 7.  Common and Divergent Mechanisms in Developmental Neuronal Remodeling and Dying Back Neurodegeneration.

Authors:  Avraham Yaron; Oren Schuldiner
Journal:  Curr Biol       Date:  2016-07-11       Impact factor: 10.834

Review 8.  Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.

Authors:  Lars Brichta; Paul Greengard
Journal:  Front Neuroanat       Date:  2014-12-15       Impact factor: 3.856

9.  Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy.

Authors:  Emily V Fletcher; Christian M Simon; John G Pagiazitis; Joshua I Chalif; Aleksandra Vukojicic; Estelle Drobac; Xiaojian Wang; George Z Mentis
Journal:  Nat Neurosci       Date:  2017-05-15       Impact factor: 24.884

Review 10.  The clinical landscape for SMA in a new therapeutic era.

Authors:  K Talbot; E F Tizzano
Journal:  Gene Ther       Date:  2017-07-23       Impact factor: 5.250

View more
  42 in total

1.  Motor neuron loss in SMA is not associated with somal stress-activated JNK/c-Jun signaling.

Authors:  Celeste M Pilato; Jae Hong Park; Lingling Kong; Constantin d'Ydewalle; David Valdivia; Karen S Chen; Irene Griswold-Prenner; Charlotte J Sumner
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

2.  Alternative Splicing in Human Biology and Disease.

Authors:  Daniel Jutzi; Marc-David Ruepp
Journal:  Methods Mol Biol       Date:  2022

3.  Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.

Authors:  Christian M Simon; Beatriz Blanco-Redondo; Jannik M Buettner; John G Pagiazitis; Emily V Fletcher; Josiane K Sime Longang; George Z Mentis
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

4.  Minor snRNA gene delivery improves the loss of proprioceptive synapses on SMA motor neurons.

Authors:  Erkan Y Osman; Meaghan Van Alstyne; Pei-Fen Yen; Francesco Lotti; Zhihua Feng; Karen Ky Ling; Chien-Ping Ko; Livio Pellizzoni; Christian L Lorson
Journal:  JCI Insight       Date:  2020-06-18

Review 5.  Revisiting the role of mitochondria in spinal muscular atrophy.

Authors:  Rachel James; Helena Chaytow; Leire M Ledahawsky; Thomas H Gillingwater
Journal:  Cell Mol Life Sci       Date:  2021-04-05       Impact factor: 9.261

6.  Control of mammalian locomotion by ventral spinocerebellar tract neurons.

Authors:  Joshua I Chalif; María de Lourdes Martínez-Silva; John G Pagiazitis; Andrew J Murray; George Z Mentis
Journal:  Cell       Date:  2022-01-20       Impact factor: 41.582

7.  Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy.

Authors:  Niko Hensel; Federica Cieri; Pamela Santonicola; Ines Tapken; Tobias Schüning; Michela Taiana; Elisa Pagliari; Antonia Joseph; Silke Fischer; Natascha Heidrich; Hella Brinkmann; Sabrina Kubinski; Anke K Bergmann; Manuela F Richter; Klaus Jung; Stefania Corti; Elia Di Schiavi; Peter Claus
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

8.  Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn2B/- mouse model of spinal muscular atrophy.

Authors:  Emily J Reedich; Martin Kalski; Nicholas Armijo; Gregory A Cox; Christine J DiDonato
Journal:  Exp Neurol       Date:  2020-12-28       Impact factor: 5.330

9.  Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit.

Authors:  Meaghan Van Alstyne; Ivan Tattoli; Nicolas Delestrée; Yocelyn Recinos; Eileen Workman; Lamya S Shihabuddin; Chaolin Zhang; George Z Mentis; Livio Pellizzoni
Journal:  Nat Neurosci       Date:  2021-04-01       Impact factor: 24.884

Review 10.  In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy.

Authors:  Kristine S Ojala; Emily J Reedich; Christine J DiDonato; Stephen D Meriney
Journal:  Brain Sci       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.